Document:

EXHIBIT 10.4
------------

      THIS WARRANT ("WARRANT") HAS NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED OR
HYPOTHECATED IN THE ABSENCE OF A REGISTRATION STATEMENT COVERING THIS
WARRANT UNDER SAID ACT OR AN EXEMPTION FROM REGISTRATION UNDER SAID ACT.

      VOID AFTER 5:00 P.M. EASTERN TIME ON JANUARY 10, 2002 ("EXPIRATION
DATE").

SUNRISE TECHNOLOGIES INTERNATIONAL, INC.

B WARRANT

WARRANT TO PURCHASE SHARES OF
COMMON STOCK, PAR VALUE $.001 PER SHARE

      This is to certify that, for VALUE RECEIVED, [_______________]
("Warrantholder"), is entitled to purchase, subject to the provisions of
this Warrant, from Sunrise Technologies International, Inc., a corporation
organized under the laws of Delaware ("Company"), at any time not later
than 5:00 P.M., Eastern time, on the Expiration Date, at an exercise price
per share equal to 115% of the Conversion Price (the exercise price in
effect from time to time hereafter being herein called the "Warrant Price")
such number of shares ("Warrant Shares") of Common Stock, par value $.001
per share ("Common Stock") of the Company equal to 25% of the sum of the
Underlying Shares (i) issued prior to March 1, 2000 and (ii) issuable on
March 1, 2000, in each case upon conversion of the Debentures purchased by
the original holder hereof pursuant to the Purchase Agreement (as defined
below) and without considering any limitations or restrictions contained in
Section 3(i) of the Debentures.  The number of Warrant Shares purchasable
upon exercise of this Warrant and the Warrant Price shall be subject to
adjustment from time to time as described herein.

      This Warrant has been issued pursuant to the terms of the Purchase
Agreement ("Purchase Agreement") dated on or about the date hereof between
the Company and the Warrantholder.  Capitalized terms used herein and not
defined shall have the meaning specified in the Purchase Agreement.

          Section 1.    Registration.  The Company shall maintain books for
the transfer and registration of the Warrant.  Upon the initial issuance of
the Warrant, the Company shall issue and register the Warrant in the name
of the Warrantholder.

          Section 2.    Transfers.  As provided herein, the Warrant may be
transferred only pursuant to a registration statement filed under the
Securities Act of 1933, as amended ("Securities Act") or an exemption from
registration thereunder.  Subject to such restrictions, the Company shall
transfer from time to time, the Warrant, upon the books to be maintained by
the Company for that purpose, upon surrender thereof for transfer properly
endorsed or accompanied by appropriate instructions for transfer upon any
such transfer, and a new Warrant shall be issued to the transferee and the
surrendered Warrant shall be canceled by the Company.

<PAGE>

          Section 3.

            (a)   Exercise of Warrant.  Subject to the provisions hereof,
the Warrantholder may exercise the Warrant in whole or in part at any time
upon surrender of the Warrant, together with delivery of the duly executed
Warrant exercise form attached hereto (the "Exercise Agreement"), to the
Company during normal business hours on any business day at the Company's
principal executive offices (or such other office or agency of the Company
as it may designate by notice to the holder hereof), and upon payment to
the Company in cash, by certified or official bank check or by wire
transfer for the account of the Company of the Warrant Price for the
Warrant Shares specified in the Exercise.  The Warrant Shares so purchased
shall be deemed to be issued to the holder hereof or such holder's
designee, as the record owner of such shares, as of the close of business
on the date on which this Warrant (or evidence of loss, theft or
destruction thereof) shall have been surrendered, the completed Exercise
Agreement shall have been delivered, and payment shall have been made for
such shares as set forth above.  Certificates for the Warrant Shares so
purchased, representing the aggregate number of shares specified in the
Exercise Agreement, shall be delivered to the holder hereof within a
reasonable time, not exceeding two (2) business days, after this Warrant
shall have been so exercised.  The certificates so delivered shall be in
such denominations as may be requested by the holder hereof and shall be
registered in the name of such holder or such other name as shall be
designated by such holder.  If this Warrant shall have been exercised only
in part, then, unless this Warrant has expired, the Company shall, at its
expense, at the time of delivery of such certificates, deliver to the
holder a new Warrant representing the number of shares with respect to
which this Warrant shall not then have been exercised.

             (b)  Redemption of Warrant.  Subject to the Purchase
Agreement, in the event that the Market Price is greater than 125% of the
Warrant Price for twenty (20) consecutive trading days ("Pre-Call Period"),
the Company shall have the right, upon at least thirty (30) business days'
prior written notice to the Warrantholder ("Redemption Notice") (the period
from the Redemption Notice to the redemption date being referred to as the
"Post-Call Period"), to redeem all or any portion of this Warrant which has
not previously been exercised, at a redemption price equal to $.01 per
Warrant Share issuable hereunder for the portion hereof being redeemed.
The Warrantholder may exercise this Warrant, including any portion subject
to a Redemption Notice, during the period from the date of such Redemption
Notice through the date on which the redemption price for such Warrants is
paid by the Company, and the Company shall honor all tendered Exercise
Agreements during such period.  Any Redemption Notice under this Section
shall be irrevocable and shall indicate the portion of this Warrant to be
redeemed and the date (subject to the terms hereof) on which such
redemption is to occur.  If the Company intends to redeem less than all of
the then outstanding Warrants issued to Investors under the Purchase
Agreement, it shall do so on a pro rata basis among such holders in
accordance with this Section.  Failure by the Company to redeem this
Warrant on a timely basis after delivering a Redemption Notice shall result
in the Company being prohibited from exercising such right pursuant to this
Section again.

            Notwithstanding anything to the contrary herein, the Company
shall be prohibited from exercising its right to redeem this Warrant
pursuant to this Section unless during the entire Pre-Call Period and Post-
Call Period (i) all the Warrant Shares with respect to this Warrant are
either (A) covered by an effective registration statement under the
Securities Act and a deliverable prospectus or (B) freely tradeable under
Rule 144(k) thereunder, and (ii) the Warrant Shares with respect to this
Warrant are listed and traded on the Nasdaq Stock Market.

<PAGE>

          Section 4.    Compliance with the Securities Act of 1933.
Neither this Warrant nor the Common Stock issued upon exercise hereof nor
any other security issued or issuable upon exercise of this Warrant may be
offered or sold except as provided in this agreement and in conformity with
the Securities Act of 1933, as amended, and then only against receipt of an
agreement of such person to whom such offer of sale is made to comply with
the provisions of this Section 4 with respect to any resale or other
disposition of such security.  The Company may cause the legend set forth
on the first page of this Warrant to be set forth on each Warrant or
similar legend on any security issued or issuable upon exercise of this
Warrant until the Warrant Shares have been registered for resale under the
Registration Rights Agreement or until Rule 144 is available, unless
counsel for the Company is of the opinion as to any such security that such
legend is unnecessary.

          Section 5.    Payment of Taxes.  The Company will pay any
documentary stamp taxes attributable to the initial issuance of Warrant
Shares issuable upon the exercise of the Warrant; provided, however, that
the Company shall not be required to pay any tax or taxes which may be
payable in respect of any transfer involved in the issue or delivery of any
certificates for Warrant Shares in a name other than that of the registered
holder of the Warrant in respect of which such shares are issued, and in
such case, the Company shall not be required to issue or deliver any
certificate for Warrant Shares or any Warrant until the person requesting
the same has paid to the Company the amount of such tax or has established
to the Company's satisfaction that such tax has been paid.  The holder
shall be responsible for income taxes due under federal or state law, if
any such tax is due.

          Section 6.    Mutilated or Missing Warrants.  In case the Warrant
shall be mutilated, lost, stolen, or destroyed, the Company shall issue in
exchange and substitution of and upon cancellation of the mutilated
Warrant, or in lieu of and substitution for the Warrant lost, stolen or
destroyed, a new Warrant of like tenor and for the purchase of a like
number of Warrant Shares, but only upon receipt of evidence reasonably
satisfactory to the Company of such loss, theft or destruction of the
Warrant, and with respect to a lost, stolen or destroyed Warrant,
reasonable indemnity or bond, if requested by the Company.

          Section 7.    Reservation of Common Stock.  The Company hereby
represents and warrants that there have been reserved, and the Company
shall at all applicable times keep reserved, out of the authorized and
unissued Common Stock, a number of shares sufficient to provide for the
exercise of the rights of purchase represented by the Warrant, and the
transfer agent for the Common Stock ("Transfer Agent"), and every
subsequent transfer agent for the Common Stock or other shares of the
Company's capital stock issuable upon the exercise of any of the right of
purchase aforesaid, shall be irrevocably authorized and directed at all
times to reserve such number of authorized and unissued shares of Common
Stock as shall be requisite for such purpose.  The Company agrees that all
Warrant Shares issued upon exercise of the Warrant shall be, at the time of
delivery of the certificates for such Warrant Shares, duly authorized,
validly issued, fully paid and non-assessable shares of Common Stock of the
Company.  The Company will keep a conformed copy of this Warrant on file
with the Transfer Agent and with every subsequent transfer agent for the
Common Stock or other shares of the Company's capital stock issuable upon
the exercise of the rights of purchase represented by the Warrant.  The
Company will supply from time to time the Transfer Agent with duly executed
stock certificates required to honor the outstanding Warrant.

          Section 8.    Warrant Price.  The Warrant Price, subject to
adjustment as provided in Section 9, shall, if payment is made in cash or
by certified check, be payable in lawful money of the United States of
America.

<PAGE>

          Section 9.    Adjustments.  Subject and pursuant to the
provisions of this Section 9, the Warrant Price and number of Warrant
Shares subject to this Warrant shall be subject to adjustment from time to
time as set forth hereinafter.

            (a)   If the Company shall at any time or from time to time
while the Warrant is outstanding, pay a dividend or make a distribution on
its Common Stock in shares of Common Stock, subdivide its outstanding
shares of Common Stock into a greater number of shares or combine its
outstanding shares into a smaller number of shares or issue by
reclassification of its outstanding shares of Common Stock any shares of
its capital stock (including any such reclassification in connection with a
consolidation or merger in which the Company is the continuing
corporation), then the number of Warrant Shares purchasable upon exercise
of the Warrant and the Warrant Price in effect immediately prior to the
date upon which such change shall become effective, shall be adjusted by
the Company so that the Warrantholder thereafter exercising the Warrant
shall be entitled to receive the number of shares of Common Stock or other
capital stock which the Warrantholder would have received if the Warrant
had been exercised immediately prior to such event.  Such adjustment shall
be made successively whenever any event listed above shall occur.

            (b)   If any capital reorganization, reclassification of the
capital stock of the Company, consolidation or merger of the Company with
another corporation, or sale, transfer or other disposition of all or
substantially all of the Company's properties to another corporation shall
be effected, then, as a condition of such reorganization, reclassification,
consolidation, merger, sale, transfer or other disposition, lawful and
adequate provision shall be made whereby each Warrantholder shall
thereafter have the right to purchase and receive upon the basis and upon
the terms and conditions herein specified and in lieu of the Warrant Shares
immediately theretofore issuable upon exercise of the Warrant, such shares
of stock, securities or properties as may be issuable or payable with
respect to or in exchange for a number of outstanding Warrant Shares equal
to the number of Warrant Shares immediately theretofore issuable upon
exercise of the Warrant, had such reorganization, reclassification,
consolidation, merger, sale, transfer or other disposition not taken place,
and in any such case appropriate provision shall be made with respect to
the rights and interests of each Warrantholder to the end that the
provisions hereof (including, without limitations, provision for adjustment
of the Warrant Price) shall thereafter be applicable, as nearly equivalent
as may be practicable in relation to any shares of stock, securities or
properties thereafter deliverable upon the exercise hereof.  The Company
shall not effect any such consolidation, merger, sale, transfer or other
disposition unless prior to or simultaneously with the consummation thereof
the successor corporation (if other than the Company) resulting from such
consolidation or merger, or the corporation purchasing or otherwise
acquiring such assets or other appropriate corporation or entity shall
assume, by written instrument executed and delivered to the Company, the
obligation to deliver to the holder of the Warrant such shares of stock,
securities or assets as, in accordance with the foregoing provisions, such
holder may be entitled to purchase and the other obligations under this
Warrant.  The provisions of this paragraph (b) shall similarly apply to
successive reorganizations, reclassifications, consolidations, mergers,
sales, transfers or other dispositions.

            (c)   In case the Company shall fix a record date for the
making of a distribution to all holders of Common Stock (including any such
distribution made in connection with a consolidation or merger in which the
Company is the continuing corporation) of evidences of indebtedness or
assets (other than cash dividends or cash distributions payable out of
consolidated earnings or earned surplus or dividends or distributions
referred to in Section 9(a)), or subscription rights or warrants, the
Warrant Price to be in effect after such record date shall be determined by

<PAGE>

multiplying the Warrant Price in effect immediately prior to such record
date by a fraction, the numerator of which shall be the total number of
shares of Common Stock outstanding multiplied by the Market Price per share
of Common Stock (as determined pursuant to Section 3), less the fair market
value (as determined by the Company's Board of Directors in good faith) of
said assets or evidences of indebtedness so distributed, or of such
subscription rights or warrants, and the denominator of which shall be the
total number of shares of Common Stock outstanding multiplied by such
current Market Price per share of Common Stock.  Such adjustment shall be
made successively whenever such a record date is fixed.

            (d)   If the Company shall at any time or from time to time
during the MFN Period (as defined in Section 7.1 of the Purchase Agreement)
issue or sell in a financing transaction (which shall not include any sales
or issuances of Common Stock after the date hereof pursuant to contractual
obligations in effect on the date hereof), (A) any shares of Common Stock
for a Per Share Selling Price (as defined in Section 7.1 of the Purchase
Agreement) less than the Warrant Price (as defined above) or (B) any
securities convertible into shares of Common Stock ("Convertible
Securities") for which the Per Share Selling Price of the Common Stock is
less than the Warrant Price (as defined above) on the date of such
issuance, then the Warrant Price shall be automatically reset (if it would
result in a reduction of such price) to a price equal to such Per Share
Selling Price, regardless of whether such adjusted Warrant Price falls
below the $3.00 floor set forth in the definition of "Conversion Price"
under the Purchase Agreement.  The number of Warrant Shares shall be
proportionally increased.  Such adjustments shall be made successively
whenever such sales are made.  If an adjustment (the "Adjustment") of the
Warrant Price is required pursuant hereto, the Company shall deliver to
each the Warrantholder within eight calendar days of the closing of the
transaction giving rise to the Adjustment ("Delivery Date") a notice
("Adjustment Notice") stating that such Warrant Price has been
automatically adjusted as of the Delivery Date, and such notice shall
constitute an amendment to this Warrant.  In the event the Company fails to
deliver the Adjustment Notice by the applicable Delivery Date, the Company
shall be liable to each Warrantholder for a delay payment equal to 2% of
(x) the number of Warrant Shares issuable hereunder times (y) the Market
Price, per month payable in Common Stock or cash, at the Warrantholder's
election (provided, that such failure to notify shall not affect automatic
adjustment of the Warrant Price).  The Company shall give to Warrantholder
written notice of any such sale of Common Stock within 24 hours of the
closing of any such sale and shall within such 24 hour period issue a press
release announcing such sale.

            (e)   An adjustment shall become effective immediately after
the record date in the case of each dividend or distribution and
immediately after the effective date of each other event which requires an
adjustment.

            (f)   In the event that, as a result of an adjustment made
pursuant to Section 9, the holder of the Warrant shall become entitled to
receive any shares of capital stock of the Company other than shares of
Common Stock, the number of such other shares so receivable upon exercise
of the Warrant shall be subject thereafter to adjustment from time to time
in a manner and on terms as nearly equivalent as practicable to the
provisions with respect to the Warrant Shares contained in this Warrant.

          Section 10.   Fractional Interest.  The Company shall not be
required to issue fractions of Warrant Shares upon the exercise of the
Warrant.  If any fraction of a Warrant Share would, except for the
provisions of this Section, be issuable upon the exercise of the Warrant
(or specified portions thereof), the Company shall round such calculation
to the nearest whole number and disregard the fraction.

<PAGE>

          Section 11.   Benefits.  Nothing in this Warrant shall be
construed to give any person, firm or corporation (other than the Company
and the Warrantholder) any legal or equitable right, remedy or claim, it
being agreed that this Warrant shall be for the sole and exclusive benefit
of the Company and the Warrantholder.

          Section 12.   Notices to Warrantholder.  Upon the happening of
any event requiring an adjustment of the Warrant Price, the Company shall
forthwith give written notice thereof to the Warrantholder at the address
appearing in the records of the Company, stating the adjusted Warrant Price
and the adjusted number of Warrant Shares resulting from such event and
setting forth in reasonable detail the method of calculation and the facts
upon which such calculation is based.  The certificate of the Company's
independent certified public accountants shall be conclusive evidence of
the correctness of any computation made, absent manifest error.  Failure to
give such notice to the Warrantholder or any defect therein shall not
affect the legality or validity of the subject adjustment.  At the
Warrantholder's request, the Company shall deliver to the Warrantholder as
of a requested date a notice specifying the number of Warrant Shares into
which this Warrant is exercisable as of such date.

          Section 13.   Identity of Transfer Agent.  The Transfer Agent for
the Common Stock is ChaseMellon Shareholder Services, c/o Gloria Pouncil,
235 Montgomery Street, 23rd Floor, San Francisco, CA  94104, Phone: (415)
643-1427.  Forthwith upon the appointment of any subsequent transfer agent
for the Common Stock or other shares of the Company's capital stock
issuable upon the exercise of the rights of purchase represented by the
Warrant, the Company will fax to the Warrantholder a statement setting
forth the name and address of such transfer agent.

          Section 14.   Notices.  Any notice pursuant hereto to be given or
made by the Warrantholder to or on the Company shall be sufficiently given
or made personally or if sent by an internationally recognized courier by
next day or two day delivery service, addressed as follows:

                        Sunrise Technologies International, Inc.
                        3400 West Warren Avenue
                        Fremont, California 94538
                        Telephone:  (510) 623-9001
                        Telefax:    (510) 623-9009
                        Attention:  Mr. Peter Jansen
                                    Chief Financial Officer

or such other address as the Company may specify in writing by notice to
the Warrantholder complying as to delivery with the terms of this
Section 14.

            Any notice pursuant hereto to be given or made by the Company
to or on the Warrantholder shall be sufficiently given or made if
personally delivered or if sent by an internationally recognized courier
service by overnight or two-day service, to the address set forth on the
books of the Company or, as to each of the Company and the Warrantholder,
at such other address as shall be designated by such party by written
notice to the other party complying as to delivery with the terms of this
Section 14.

            All such notices, requests, demands, directions and other
communications shall, when sent by courier, be effective two (2) days after
delivery to such courier as provided and addressed as aforesaid.

          Section 15.   Registration Rights.  The initial holder of this
Warrant is entitled to the benefit of certain registration rights in
respect of the Warrant Shares as provided in the Registration Rights
Agreement.

<PAGE>

          Section 16.   Successors.  All the covenants and provisions
hereof by or for the benefit of the Warrantholder shall bind and inure to
the benefit of its respective successors and permitted assigns hereunder.
The Warrantholder may assign or transfer this Warrant to any transferee
only with the prior consent of the Company, which may not be unreasonably
withheld or delayed, provided that the Warrantholder may assign or transfer
this Warrant to any of its affiliates without the consent of the Company.

          Section 17.   Governing Law.  This Warrant shall be deemed to be
a contract made under the laws of the State of New York, and for all
purposes shall be construed in accordance with the laws of said State.

          Section 18.   9.9% and 19.9% Limitations.

                  (a)   Notwithstanding anything to the contrary contained
herein, the number of shares of Common Stock that may be acquired by the
holder upon exercise pursuant to the terms hereof shall not exceed a number
that, when added to the total number of shares of Common Stock deemed
beneficially owned by such holder (other than by virtue of the ownership of
securities or rights to acquire securities that have limitations on the
Holder's right to convert, exercise or purchase similar to the limitation
set forth herein), together with all shares of Common Stock deemed
beneficially owned by the holder's "affiliates" (as defined in Rule 144 of
the Securities Act) that would be aggregated for purposes of determining
whether a group under Section 13(d) of the Securities Exchange Act of 1934,
as amended, exists, would exceed 9.99% of the total issued and outstanding
shares of the Company's Common Stock (the "Restricted Ownership
Percentage"); provided that (w) each holder shall have the right at any
time and from time to time to reduce its Restricted Ownership Percentage
immediately upon notice to the Company and (x) each holder shall have the
right at any time and from time to time, to increase its Restricted
Ownership Percentage immediately (subject to waiver) in the event of a
pending or announced change of control transaction (including without
limitation a transaction that would result in a transfer of more than 50%
of the Company's voting power or equity, or a transaction that would result
in a person or "group" being deemed the beneficial owner of 50% or more of
the Company's voting power or equity).

            (b)   Each time (a "Covenant Time") the holder makes a
Triggering Acquisition (as defined below) of shares of Common Stock (the
"Triggering Shares") pursuant to the Agreement, the holder will be deemed
to covenant that it will not, during the balance of the day on which such
Triggering Acquisition occurs, and during the 61-day period beginning
immediately after that day, acquire additional shares of Common Stock
pursuant to Warrants existing at that Covenant Time, if the aggregate
amount of such additional shares so acquired (without reducing that amount
by any dispositions) would exceed (x) 9.99% of the number of shares of
Common Stock outstanding at that Covenant Time (including the Triggering
Shares) minus (y) the number of shares of Common Stock actually owned by
the Holder at that Covenant Time (regardless of how or when acquired, and
including the Triggering Shares).  "Triggering Acquisition" means the
exercise of the Warrant by the holder; provided, however, that with respect
to the exercise of this Warrant, if the associated issuance of shares of
Common Stock does not occur, such event shall cease to be a Triggering
Acquisition and the related covenant under this paragraph shall terminate.
At each Covenant Time, the Holder shall be deemed to waive any right it
would otherwise have to acquire shares of Common Stock to the extent that
such acquisition would violate any covenant given by the Holder under this
paragraph.

                  (i)   The covenant to be given pursuant to this paragraph
will be given at every Covenant Time and shall be calculated based on the
circumstances then in effect.  The making of a covenant at one Covenant
Time shall not terminate or modify any prior covenants.

<PAGE>

                  (ii)  The Warrantholder may therefore from time to time
be subject to multiple such covenants, each one having been made at a
different Covenant Time, and some possibly being more restrictive than
others.  The Warrantholder must comply with all such covenants then in
effect.

                  (c)   Notwithstanding anything contained herein, in no
event shall the Company issue shares of Common Stock hereunder to the
extent that the total number of shares issued or deemed issued to the
Investors (when added to the Underlying Shares and Warrant Shares) under
the Purchase Agreement would exceed 19.9% of the Company's issued and
outstanding shares of Common Stock on the date hereof.  Instead, the
Company shall redeem this Warrant to the extent necessary at such
consideration required to place the Investors in the same economic position
they would have been if not for such limitation.  Only shares acquired
pursuant to the Purchase Agreement will be included in determining whether
the limitation would be exceeded for purposes of this paragraph.

                         [Signature Page Follows]

<PAGE>

      IN WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed as of January 10, 2000.

                        SUNRISE TECHNOLOGIES INTERNATIONAL, INC.

                        By:___________________________
                        Name:
                        Title:

Attest:

______________________________

<PAGE>

                 SUNRISE TECHNOLOGIES INTERNATIONAL, INC.
                           WARRANT EXERCISE FORM

Sunrise Technologies International, Inc.
3400 West Warren Avenue
Fremont, California 94538
Telephone:(510) 623-9001
Telefax:(510) 623-9009
Attention:  Mr. Peter Jansen
            Chief Financial Officer

      This undersigned hereby irrevocably elects to exercise the right of
purchase represented by the within Warrant ("Warrant") for, and to purchase
thereunder by (CHECK AS APPLICABLE):

      [  ]  payment by cash, wire or certified check,
      [  ]  conversion of the within Warrant by surrender of the Warrant,
_______________ shares of Common Stock* ("Warrant Shares") provided for
therein, and requests that certificates for the Warrant Shares be issued as
follows:
                  _______________________________

                  Name
                  ________________________________
                  Address
                  ________________________________
                  ________________________________

and, if the number of Warrant Shares shall not be all the Warrant Shares
purchasable upon exercise of the Warrant, that a new Warrant for the
balance of the Warrant Shares.

      In lieu of delivering physical certificates representing the Warrant
Shares purchasable upon exercise of this Warrant, provided the Company's
transfer agent is participating in the Depository Trust Company ("DTC")
Fast Automated Securities Transfer ("FAST") program, upon request of the
Holder, the Company shall use its best efforts to cause its transfer agent
to electronically transmit the Warrant Shares issuable upon conversion or
exercise to the undersigned, by crediting the account of the undersigned's
prime broker with DTC through its Deposit Withdrawal Agent Commission
("DWAC") system.

Dated:            ______________________________

Signature:        ______________________________

                  ______________________________

Name (please print)
                  _______________________________

Address
                  _______________________________

   *  NOTE:  If conversion of the Warrant is made by surrender of the
Warrant and the number of shares indicated exceeds the maximum number of
shares to which a holder is entitled, the Company will issue such maximum
number of shares purchasable upon exercise of the Warrant registered in the
name of the undersigned Warrantholder or the undersigned's Assignee as
below indicated and deliver same to the address stated below.EXHIBIT 10.5
------------

                       REGISTRATION RIGHTS AGREEMENT
                       -----------------------------

      This Registration Rights Agreement (the "Agreement") is made and
entered as of this 11th day of January, 2000 by and between Sunrise
Technologies International, Inc., a corporation organized under the laws of
Delaware (the "Company"), Dunwoody Brokerage Services, Inc. ("Dunwoody"),
and the persons listed on the signature page hereto ("Initial Investors")
pursuant to the Purchase Agreement of even date herewith by and between the
Company and the Initial Investors.

            The parties hereby agree as follows:

          1.      Certain Definitions

                  As used in this Agreement, the following terms shall have
the following meanings:

                  "Additional Registrable Securities" shall mean, to the
extent not included in the definition of "Registrable Securities," any
additional shares of Common Stock, if any, issuable or issued to the
Investors pursuant to Purchase Agreement, Debenture or Warrants.

                  "Common Stock" shall mean the Company's shares of Common
Stock, par value $.001 per share.

                  "Investor" shall mean the Initial Investors and Dunwoody
and any subsequent holder of any Common Stock, Debentures, Warrants or
Registrable Securities.

                  "Prospectus" shall mean the prospectus included in any
Registration Statement, as amended or supplemented by any prospectus
supplement, with respect to the terms of the offering of any portion of the
Registrable Securities and Additional Registrable Securities covered by
such Registration Statement and by all other amendments and supplements to
the prospectus, including post-effective amendments and all material
incorporated by reference in such prospectus.

                  "Register," "registered" and "registration" refer to a
registration made by preparing and filing a registration statement or
similar document in compliance with the 1933 Act (as defined below), and
the declaration or ordering of effectiveness of such registration statement
or document.

                  "Registrable Securities" shall mean the shares of Common
Stock issued and issuable to the Investors pursuant to the Purchase
Agreement and issuable upon conversion of or payment for interest under the
Debentures and upon the exercise of the Warrants and issuable to Dunwoody
upon exercise of the Dunwoody Warrant, and any securities issued with
respect to, or in exchange for, such securities (including without
limitation additional shares issuable following any adjustment described in
Section 7.1 of the Purchase Agreement).

                  "Registration Statement" shall mean any registration
statement filed under the 1933 Act of the Company that covers the resale of
any of the Registrable Securities or Additional Registrable Securities
pursuant to the provisions of this Agreement, amendments and supplements to
such Registration Statement, including post-effective amendments, all
exhibits and all material incorporated by reference in such Registration
Statement.

<PAGE>

                  "SEC" means the U.S. Securities and Exchange Commission.

                  "1933 Act" means the Securities Act of 1933, as amended,
and the rules and regulations promulgated thereunder.

                  "1934 Act" means the Securities Exchange Act of 1934, as
amended, and the rules and regulations promulgated thereunder.

                  "Warrants" mean the warrants to purchase shares of Common
Stock issued to the Investors pursuant to the Purchase Agreement.

                  Other capitalized terms used herein but not defined
herein shall have the meaning provided therefor in the Purchase Agreement.

          2.      Registration.

               (a)      Registration Statement.  Promptly following the
closing of the transactions contemplated by the Purchase Agreement (the
"Closing Date") (but no later than 45 days after the Closing Date), the
Company shall prepare and file with the SEC one Registration Statement on
Form S-3 (or, if Form S-3 is not then available to the Company, on such
form of registration statement as is then available to effect a
registration for resale of the Registrable Securities, subject to the
Investors' consent) covering the resale of the Registrable Securities.
Such Registration Statement shall cover, to the extent allowable under the
1933 Act and the Rules promulgated thereunder (including Rule 416), such
indeterminate number of additional shares of Common Stock resulting from
stock splits, stock dividends or similar transactions with respect to the
Registrable Securities.  No securities shall be included in the
Registration Statement without the consent of the Investors other than the
Registrable Securities.  The Registration Statement (and each amendment or
supplement thereto, and each request for acceleration of effectiveness
thereof) shall be provided in accordance with Section 3(c) to (and subject
to the approval of) the Investors and their counsel prior to its filing or
other submission, which approval shall not be unreasonably withheld or
delayed.

<PAGE>

               (b)      Expenses.  The Company will pay all expenses
associated with the registration, excluding discounts, commissions, fees of
underwriters, selling brokers, dealer managers or similar securities
industry professionals and excluding legal fees of the Investors.

               (c)      Effectiveness.

                    (i) The Company shall use its best efforts to have the
Registration Statement declared effective as soon as practicable.  If (A)
the Registration Statement is not declared effective by the SEC within 90
days following the Closing Date or, if the Registration Statement is
subject to full SEC review (which excludes "plain English" and other
immaterial comments), then within 20 days following the Closing Date (in
either case, the "Registration Date"), or (B) after the Registration
Statement has been declared effective by the SEC, sales cannot be made
pursuant to the Registration Statement for any reason but except as excused
pursuant to subparagraph (ii) below, then the Company will make payments to
each Investor, as damages and not as a penalty, for any 30 day period or
portion thereof following the Registration Date during which any of the
events described in (A) or (B) above occurs and is continuing (the
"Blackout Period") in an amount equal to 2% of the aggregate Purchase Price
paid by such Investor to the Company on the Closing Date.  The amounts
payable as damages pursuant to this paragraph shall be payable in lawful
money of the United States and shall be paid on demand from time to time
following the commencement of the Blackout Period until the termination of
the Blackout Period.  The same remedy shall be available in the case of any
failure to timely issue Underlying Shares upon conversion of the Debentures
or Warrant Shares upon exercise of the Warrants, or in the case of any
suspension from trading or delisting of the Common Stock from the Nasdaq
Stock Market.  If at any time a payment due hereunder remains unpaid for
more than sixty (60) days after demand, the rate of damage payments shall
thereafter be increased for all purposes to a rate equal to 3% per 30 day
period.  The remedies set forth in this section are not intended to be
exclusive, and shall be in addition to any other remedies available at law
or in equity.  Amounts payable as damages hereunder shall cease when the
Investors no longer hold any Debentures, Warrants or Registrable
Securities, or Additional Registrable Securities, as applicable.

                        (ii)  The Company may terminate or suspend
effectiveness of any registration contemplated by this Section one time for
a period of not more than twenty (20) days if the Company shall deliver to
the Investors a certificate signed by the President of the Company stating
that, in the good faith judgment of the Board of Directors of the Company,
it would (A) be seriously detrimental to the business of the Company for
such registration to be effected or remain effective at such time, (B)
interfere with any proposed or pending material corporate transaction
involving the Company or any of its subsidiaries, or (C) result in any
premature disclosure thereof.  In such a case, the Company shall not
disclose to an Investor any facts or circumstances constituting material
non-public information, without the prior written consent of such Investor.

The duration of the MFN Period provided for in the Purchase Agreement, the
Debentures and the Warrants will be extended by the number of days of (x)
any termination or suspension of the effectiveness of any registration
contemplated by this Section 2, and (y) without duplicating, the number of
days in any Blackout Period (computed as if the excused period in this
subsection (c)(ii) did not apply).

               (d)      Promptly following the issuance of any Additional
Registrable Securities, the Company shall file a Registration Statement and
use its best efforts to have such Registration Statement covering the
Additional Registrable Securities declared effective as soon as possible.
All time periods, provisions, rights and remedies covering the registration
of Registrable Securities shall apply, mutatis mutandis, to the
registration of the Additional Registrable Securities.

<PAGE>

          3.      Company Obligations.  The Company will use its best
efforts to effect the registration of the Registrable Securities and
Additional Registrable Securities in accordance with the terms hereof, and
pursuant thereto the Company will, as expeditiously as possible:

               (a)      use its best efforts to cause such Registration
Statement to become effective and to remain continuously effective for a
period that will terminate upon the later of (i) thirty (30) months
following the effective date of the Registration Statement and (ii) the
earlier of the date on which all Registrable Securities or Additional
Registrable Securities, as the case may be, covered by such Registration
Statement, as amended from time to time, have been sold or until such time
as they become eligible for distribution pursuant to Rule 144(k), or any
successor provision thereof, under the 1933 Act (the "Registration
Period");

               (b)      prepare and file with the SEC such amendments and
post-effective amendments to the Registration Statement and the Prospectus
as may be necessary to keep the Registration Statement effective for the
period specified in Section 3(a) and to comply with the provisions of the
1933 Act and the 1934 Act with respect to the distribution of all
Registrable Securities and Additional Registrable Securities; provided
that, at a time reasonably prior to the filing of a Registration Statement
or Prospectus, or any amendments or supplements thereto, the Company will
furnish to the Investors copies of all documents proposed to be filed,
which documents will be subject to the comments of the Investors;

               (c)      permit a single firm of counsel designated by the
Investors to review the Registration Statement and all amendments and
supplements thereto no fewer than ten (10) days prior to their filing with
the SEC, and not file any document in a form to which such counsel
reasonably objects;

               (d)      furnish to the Investors and their legal counsel
(i) promptly after the same is prepared and publicly distributed, filed
with the SEC, or received by the Company, one copy of the Registration
Statement and any amendment thereto, each preliminary prospectus and
Prospectus and each amendment or supplement thereto, and each letter
written by or on behalf of the Company to the SEC or the staff of the SEC,
and each item of correspondence from the SEC or the staff of the SEC, in
each case relating to such Registration Statement (other than any portion
of any thereof which contains information for which the Company has sought
confidential treatment), and (ii) such number of copies of a Prospectus,
including a preliminary prospectus, and all amendments and supplements
thereto and such other documents as such Investor may reasonably request in
order to facilitate the disposition of the Registrable Securities and
Additional Registrable Securities owned by such Investor;

               (e)      make reasonable effort to prevent the issuance of
any stop order or other suspension of effectiveness and, if such order is
issued, obtain the withdrawal of any such order at the earliest possible
moment;

               (f)      furnish to the Investors at least five copies of
the Registration Statement and any post-effective amendment thereto,
including financial statements and schedules by courier pursuant to the
notice requirements of Section 10.4 of the Purchase Agreement;

               (g)      prior to any public offering of Registrable
Securities and/or Additional Registrable Securities, use its best efforts
to register or qualify or cooperate with the Investors and their counsel in
connection with the registration or qualification of such Registrable
Securities or Additional Registrable Securities, as applicable, for offer
and sale under the securities or blue sky laws of all U.S. jurisdictions
and do any and all other reasonable acts or things necessary or advisable
to enable the distribution in such jurisdictions of the Registrable
Securities or Additional Registrable Securities covered by the Registration
Statement;

<PAGE>

               (h)      cause all Registrable Securities and/or Additional
Registrable Securities covered by the Registration Statement to be listed
on each securities exchange, interdealer quotation system or other market
on which similar securities issued by the Company are then listed;

               (i)      immediately notify the Investors, at any time when
a Prospectus relating to the Registrable Securities and/or Additional
Registrable Securities is required to be delivered under the Securities
Act, upon discovery that, or upon the happening of any event as a result of
which, the Prospectus included in such Registration Statement, as then in
effect, includes an untrue statement of a material fact or omits to state
any material fact required to be stated therein or necessary to make the
statements therein not misleading in the light of the circumstances then
existing, and at the request of any such holder, promptly prepare and
furnish to such holder a reasonable number of copies of a supplement to or
an amendment of such Prospectus as may be necessary so that, as thereafter
delivered to the purchasers of such Registrable Securities or Additional
Registrable Securities, as applicable, such Prospectus shall not include an
untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein
not misleading in the light of the circumstances then existing; and

               (j)      otherwise use its best efforts to comply with all
applicable rules and regulations of the SEC under the 1933 Act and the 1934
Act, take such other actions as may be reasonably necessary to facilitate
the registration of the Registrable Securities and Additional Registrable
Securities hereunder.

          4.      Obligations of the Investors.

               (a)      It shall be a condition precedent to the
obligations of the Company to complete the registration pursuant to this
Agreement with respect to the Registrable Securities and/or Additional
Registrable Securities, if applicable, that each Investor shall furnish in
writing to the Company such information regarding itself, the Registrable
Securities and/or Additional Registrable Securities, as applicable, held by
it and the intended method of disposition of the Registrable Securities
and/or Additional Registrable Securities, as applicable, held by it as
shall be reasonably required to effect the registration of such Registrable
Securities and/or Additional Registrable Securities, as applicable, and
shall execute such documents in connection with such registration as the
Company may reasonably request.  At least ten (10) business days prior to
the first anticipated filing date of the Registration Statement, the
Company shall notify the Investors of the information the Company requires
from each Investor if such Investor elects to have any of the Registrable
Securities and/or Additional Registrable Securities included in the
Registration Statement.

               (b)      Each Investor, by its acceptance of the Registrable
Securities and Additional Registrable Securities, if any, agrees to
cooperate with the Company as reasonably requested by the Company in
connection with the preparation and filing of the Registration Statement
hereunder, unless such Investor has notified the Company in writing of its
election to exclude all of its Registrable Securities or Additional
Registrable Securities, as applicable, from the Registration Statement.

               (c)      In the event the Investors determine to engage the
services of an underwriter, the Investors agree to enter into and perform
their obligations under an underwriting agreement, in usual and customary
form, including, without limitation, customary indemnification and
contribution obligations, with the managing underwriter of such offering
and take such other actions as are reasonably required in order to expedite
or facilitate the dispositions of the Registrable Securities and/or
Additional Registrable Securities, as applicable.

<PAGE>

               (d)      Each Investor agrees that, upon receipt of any
notice from the Company of the happening of any event rendering the
Registration Statement no longer effective, the Investor will immediately
discontinue disposition of Registrable Securities or Additional Registrable
Securities pursuant to the Registration Statement covering such Registrable
Securities or Additional Registrable Securities until the Investor's
receipt of the copies of the supplemented or amended prospectus filed with
the SEC and declared effective and, if so directed by the Company, the
Investor shall deliver to the Company (at the expense of the Company) or
destroy (and deliver to the Company a certificate of destruction) all
copies in the Investor's possession of the prospectus covering the
Registrable Securities or Additional Registrable Securities, as applicable,
current at the time of receipt of such notice.

               (e)      An Investor may not participate in any underwritten
registration hereunder unless it (i) agrees to sell the Registrable
Securities or Additional Registrable Securities, as applicable, on the
basis provided in any underwriting arrangements in usual and customary form
entered into by the Company, (ii) completes and executes all
questionnaires, powers of attorney, indemnities, underwriting agreements
and other documents reasonably required under the terms of such
underwriting arrangements, and (iii) agrees to pay its pro rata share of
all underwriting discounts and commissions and any expenses in excess of
those payable by the Company pursuant to the terms of this Agreement.

          5.      Indemnification.

               (a)      Indemnification by Company.  The Company agrees to
indemnify and hold harmless, to the fullest extent permitted by law each
Investor, its officers, directors, partners, members, managers and
employees and each person who controls such Investor (within the meaning of
the 1933 Act) against all losses, claims, damages, liabilities, costs
(including, without limitation, reasonable attorney's fees) and expenses
caused by (i) any untrue or alleged untrue statement of a material fact
contained in any Registration Statement, Prospectus or any preliminary
prospectus or any amendment or supplement thereto or any omission or
alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading, except
insofar as the same are based upon any information furnished in writing to
the Company by such Investor, expressly for use therein, or (ii) any
violation by the Company of any federal, state or common law, rule or
regulation applicable to the Company in connection with any Registration
Statement, Prospectus or any preliminary prospectus, or any amendment or
supplement thereto, and shall reimburse in accordance with subparagraph (c)
below, each of the foregoing persons for any legal and any other expenses
reasonably incurred in connection with investigating or defending any such
claims.  The foregoing is subject to the condition that, insofar as the
foregoing indemnities relate to any untrue statement, alleged untrue
statement, omission or alleged omission made in any preliminary prospectus
or Prospectus that is eliminated or remedied in any Prospectus or amendment
or supplement thereto, the above indemnity obligations of the Company shall
not inure to the benefit of any indemnified party if a copy of such
corrected Prospectus or amendment or supplement thereto had been made
available to such indemnified party and was not sent or given by such
indemnified party at or prior to the time such action was required of such
indemnified party by the 1933 Act and if delivery of such Prospectus or
amendment or supplement thereto would have eliminated (or been a sufficient
defense to) any liability of such indemnified party with respect to such
statement or omission.  Indemnity under this Section 5(a) shall remain in
full force and effect regardless of any investigation made by or on behalf
of any indemnified party and shall survive the permitted transfer of the
Registrable Securities and Additional Registrable Securities.

<PAGE>

               (b)      Indemnification by Holder of Registrable
Securities.  In connection with any registration pursuant to the terms of
this Agreement, each Investor severally will furnish to the Company in
writing such information as the Company reasonably requests concerning the
holders of Registrable Securities and Additional Registrable Securities or
the proposed manner of distribution for use in connection with any
Registration Statement or Prospectus and severally (and not jointly) agrees
to indemnify and hold harmless, to the fullest extent permitted by law, the
Company, its directors, officers, employees, stockholders and each person
who controls the Company (within the meaning of the 1933 Act) against any
losses, claims, damages, liabilities and expense (including reasonable
attorney's fees) resulting from any untrue statement of a material fact or
any omission of a material fact required to be stated in the Registration
Statement or Prospectus or preliminary prospectus or amendment or
supplement thereto or necessary to make the statements therein not
misleading, to the extent, but only to the extent that such untrue
statement or omission is contained in any information furnished in writing
by such holder of Registrable Securities or Additional Registrable
Securities to the Company specifically for inclusion in such Registration
Statement or Prospectus or amendment or supplement thereto and that such
information was substantially relied upon by the Company in preparation of
the Registration Statement or Prospectus or any amendment or supplement
thereto.  In no event shall the liability of a holder of Registrable
Securities or Additional Registrable Securities be greater in amount than
the dollar amount of the proceeds (net of all expense paid by such holder
and the amount of any damages such holder has otherwise been required to
pay by reason of such untrue statement or omission) received by such holder
upon the sale of the Registrable Securities or Additional Registrable
Securities included in the Registration Statement giving rise to such
indemnification obligation.

               (c)      Conduct of Indemnification Proceedings.  Any person
entitled to indemnification hereunder shall (i) give prompt notice to the
indemnifying party of any claim with respect to which it seeks
indemnification and (ii) permit such indemnifying party to assume the
defense of such claim with counsel reasonably satisfactory to the
indemnified party; provided that any person entitled to indemnification
hereunder shall have the right to employ separate counsel and to
participate in the defense of such claim, but the fees and expenses of such
counsel shall be at the expense of such person unless (a) the indemnifying
party has agreed to pay such fees or expenses, or (b) the indemnifying
party shall have failed to assume the defense of such claim and employ
counsel reasonably satisfactory to such person or (c) in the reasonable
judgment of any such person, based upon written advice of its counsel, a
conflict of interest exists between such person and the indemnifying party
with respect to such claims (in which case, if the person notifies the
indemnifying party in writing that such person elects to employ separate
counsel at the expense of the indemnifying party, the indemnifying party
shall not have the right to assume the defense of such claim on behalf of
such person); and provided, further, that the failure of any indemnified
party to give notice as provided herein shall not relieve the indemnifying
party of its obligations hereunder, except to the extent that such failure
to give notice shall materially adversely affect the indemnifying party in
the defense of any such claim or litigation.  It is understood that the
indemnifying party shall not, in connection with any proceeding in the same
jurisdiction, be liable for fees or expenses of more than one separate firm
of attorneys at any time for all such indemnified parties.  No indemnifying
party will, except with the consent of the indemnified party, consent to
entry of any judgment or enter into any settlement that does not include as
an unconditional term thereof the giving by the claimant or plaintiff to
such indemnified party of a release from all liability in respect to such
claim or litigation.

<PAGE>

               (d)      Contribution.  If for any reason the
indemnification provided for in the preceding paragraphs (a) and (b) is
unavailable to an indemnified party or insufficient to hold it harmless,
other than as expressly specified therein, then the indemnifying party
shall contribute to the amount paid or payable by the indemnified party as
a result of such loss, claim, damage or liability in such proportion as is
appropriate to reflect the relative fault of the indemnified party and the
indemnifying party, as well as any other relevant equitable considerations.

No person guilty of fraudulent misrepresentation within the meaning of
Section 11(f) of the 1933 Act shall be entitled to contribution from any
person not guilty of such fraudulent misrepresentation.  In no event shall
the contribution obligation of a holder of Registrable Securities or
Additional Registrable Securities be greater in amount than the dollar
amount of the proceeds (net of all expenses paid by such holder and the
amount of any damages such holder has otherwise been required to pay by
reason of such untrue or alleged untrue statement or omission or alleged
omission) received by it upon the sale of the Registrable Securities or
Additional Registrable Securities giving rise to such contribution
obligation.

          6.      Miscellaneous.

               (a)      Amendments and Waivers.  This Agreement may be
amended only by a writing signed by the parties hereto intended to be
bound.  The Company may take any action herein prohibited, or omit to
perform any act herein required to be performed by it, only if the Company
shall have obtained the written consent to such amendment, action or
omission to act, of the Investor(s) affected by such amendment, action or
omission to act.

               (b)      Notices.  All notices and other communications
provided for or permitted hereunder shall be made as set forth in Section
10.4 of the Purchase Agreement.

               (c)      Assignments and Transfers by Investors.  This
Agreement and all the rights and obligations of the Investors hereunder may
not be assigned or transferred to any transferee or assignee except as set
forth herein.  An Investor may make such assignment or transfer to any
transferee or assignee of any Common Stock, Debenture, Warrant, Dunwoody
Warrant or Registrable Securities, or Additional Registrable Securities,
provided, that (i) such transfer is made expressly subject to this
Agreement and the transferee agrees in writing to be bound by the terms and
conditions hereof, and (ii) the Company is provided with written notice of
such assignment.

               (d)      Assignments and Transfers by the Company.  This
Agreement may not be assigned by the Company without the prior written
consent of the Investors, except that without the prior written consent of
the Investors, but after notice duly given, the Company shall assign its
rights and delegate its duties hereunder to any successor-in-interest
corporation, and such successor-in-interest shall assume such rights and
duties, in the event of a merger or consolidation of the Company with or
into another corporation or the sale of all or substantially all of the
Company's assets.

               (e)      Benefits of the Agreement.  The terms and
conditions of this Agreement shall inure to the benefit of and be binding
upon the respective permitted successors and assigns of the parties.
Nothing in this Agreement, express or implied, is intended to confer upon
any party other than the parties hereto or their respective successors and
assigns any rights, remedies, obligations, or liabilities under or by
reason of this Agreement, except as expressly provided in this Agreement.

<PAGE>

               (f)      Counterparts.  This Agreement may be executed in
two or more counterparts, each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument.

               (g)      Titles and Subtitles.  The titles and subtitles
used in this Agreement are used for convenience only and are not to be
considered in construing or interpreting this Agreement.

               (h)      Severability.  If one or more provisions of this
Agreement are held to be unenforceable under applicable law, such provision
shall be excluded from this Agreement and the balance of this Agreement
shall be interpreted as if such provision were so excluded and shall be
enforceable in accordance with its terms to the fullest extent permitted by
law.

               (i)      Further Assurances.  The parties shall execute and
deliver all such further instruments and documents and take all such other
actions as may reasonably be required to carry out the transactions
contemplated hereby and to evidence the fulfillment of the agreements
herein contained.

               (j)      Entire Agreement.  This Agreement is intended by
the parties as a final expression of their agreement and intended to be a
complete and exclusive statement of the agreement and understanding of the
parties hereto in respect of the subject matter contained herein.  This
Agreement supersedes all prior agreements and understandings between the
parties with respect to such subject matter.

               (k)      Applicable Law.  This Agreement shall be governed
by, and construed in accordance with, the laws of the State of New York
without regard to principles of conflicts of law.

                  [REMAINDER OF PAGE INTENTIONALLY BLANK]

<PAGE>

                  IN WITNESS WHEREOF, the parties have executed this
Agreement as of the date first written above.

The Company:                  SUNRISE TECHNOLOGIES
                              INTERNATIONAL, INC.

                              By:_________________________
                              Name:
                              Title:

Placement Agent:              DUNWOODY BROKERAGE SERVICES, INC.

                              By:_________________________
                              Name:
                              Title:

The Investors:                THE TAIL WIND FUND, LTD.

                              By:_________________________
                              Name:
                              Title:

                              JEDDY DEVELOPMENT INC.

                              By:_________________________
                              Name:  Pablo Javier Espino
                              Title:  President

                              LBI GROUP INC.

                              By:_________________________
                              Name: Steven L. Berkenfeld
                              Title:     Senior Vice President

                              ____________________________
                              Donald Sanders MD, PhD

                              DONALD SANDERS, IRA,
                              CIBC OPPENHEIMER CORP AS CUSTODIAN

                              By:_________________________
                              Name: Donald Sanders MD, PhD
                              Title:     Beneficiary

<PAGE>

                              ____________________________
                              Donald Sanders MD, PhD, as guardian for
                              Monica Sanders

                              ____________________________
                              Donald Sanders MD, PhD, as guardian for
                              Kendra Sanders

                              WANDA SANDERS, IRA,
                              CIBC OPPENHEIMER CORP AS CUSTODIAN

                              By:_________________________
                              Name: Wanda Sanders
                              Title:     Beneficiary

                              ____________________________
                              Meyer Temkin

                              ____________________________
                              Charles D. Kelman, M.D.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00000-of-00352.parquet"}]]